|
The overall goal of the
NIH-sponsored CRCA is to support a structured program at Tulane
University Health Sciences Center to develop effective clinical
researchers from promising advanced trainees in clinically-related
disciplines. The Tulane CRCA Program is a 2-year graduate
training program in clinical research that is a joint educational
enterprise of the Tulane Schools of Medicine and Public Health
and Tropical Medicine. This program will bring together trainees
from a diverse background, including Tulane Medical School,
Tulane School of Public Health and Tropical Medicine, Tulane
Department of Biomedical Engineering and the Xavier University
College of Pharmacy, to enable the development and training
of creative, independent, and productive clinical investigators.
As part of the development of the program, a new Master of
Public Health in Clinical Research degree awarded by the Tulane
School of Public Health and Tropical Medicine has been established.
Trainees in the CRCA Program will acquire the necessary skills
to design and conduct clinical investigations into emerging
medical treatments and technologies, new diagnostic techniques,
and new approaches to the study of pathobiology. Tulane University
Health Sciences Center and its associated hospitals including
the Medical Center of Louisiana at New Orleans (formerly Charity
Hospital of New Orleans), and the New Orleans Veterans Affairs
Medical Center serves a multi-ethnic population. A large proportion
of patients are African-American, Hispanics and Asians. Furthermore,
a broad spectrum of disease conditions are seen, including
arthritis, asthma, cancer, heart failure, hypertension, genetic
disorders, COPD, diabetes, HIV and renal disease. This diverse
patient population ensures the exposure of the CRCA trainees
to important populations. Lastly, the CRCA Program will develop
interests in clinical research at an early phase of training.
Prior to the CRCA program,
participants in the various training programs of Tulane University
Medical Center, Xavier's College of Pharmacy, and the Tulane
Department of Biomedical Engineering had very little formal
training in the techniques and science of clinical investigation.
Specifically, rarely did trainees pursue questions related
to efficacy and effectiveness of therapy, issues involving
design and validation of clinical studies, epidemiology and
advanced biostatistics, or considerations of quality of life,
health behavior and policy analysis. Thus the CRCA program
will be beneficial to current and future trainees.
The CRCA curriculum offers
both basic and clinical research training resulting in expansion
of the pool of well-trained clinical investigators. Opening
the CRCA curriculum to additional trainees outside of Tulane
Health Sciences Center (i.e., trainees with graduate degrees
in pharmacy and biomedical engineering) further expands the
group of trainees resulting in a broad base of individuals
to become independent, funded and committed clinical investigators.
|